All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
LONDON – Two years after halting development of bovine alkaline phosphatase, AM-Pharma is back in the clinic with its new, proprietary, recombinant human version of the anti-inflammatory enzyme.
